Acorda Therapeutics, Inc. - Strategy and SWOT Report,
- is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Features:
- Detailed information on Acorda Therapeutics, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Acorda Therapeutics, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Acorda Therapeutics, Inc. including a breakdown and examination of key business segments
- Intelligence on Acorda Therapeutics, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Acorda Therapeutics, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:Acorda Therapeutics (Acorda or 'the company') is a commercial-stage biotechnology company engaged in the development and marketing of therapies to help restore function in persons with spinal cord injury, multiple sclerosis and related conditions of the central nervous system. The company primarily operates in the US, where it is headquartered in Ardsley, New York. Acorda employed 489 people as on February 19, 2015.
Reasons to Purchase:Gain understanding of Acorda Therapeutics, Inc. and the factors that influence its strategies Track strategic initiatives of the company and latest corporate news and actions Assess Acorda Therapeutics, Inc. as a prospective partner, vendor or supplierSupport sales activities by understanding your customers' businesses betterStay up to date on Acorda Therapeutics, Inc.’s business structure, strategy and prospects
- Company Snapshot
- Acorda Therapeutics, Inc.: Company Overview
- Acorda Therapeutics, Inc.: Overview and Key Facts
- Acorda Therapeutics, Inc.: Overview
- Acorda Therapeutics, Inc.: Key Facts
- Acorda Therapeutics, Inc.: Key Employees
- Acorda Therapeutics, Inc.: Key Employee Biographies
- Acorda Therapeutics, Inc.: Major Products and Services
- Acorda Therapeutics, Inc.: Company History
- Acorda Therapeutics, Inc.: Management Statement
- Acorda Therapeutics, Inc.: Key Competitors
- Acorda Therapeutics, Inc.: Company Analysis
- Acorda Therapeutics, Inc.: Business Description
- Acorda Therapeutics, Inc.: SWOT Analysis
- Acorda Therapeutics, Inc.: SWOT Overview
- Acorda Therapeutics, Inc.: Strengths
- Acorda Therapeutics, Inc.: Weaknesses
- Acorda Therapeutics, Inc.: Opportunities
- Acorda Therapeutics, Inc.: Threats
- Acorda Therapeutics, Inc.: Corporate Financial Deals Activity
- Acorda Therapeutics, Inc.: Financial Deals Overview
- Acorda Therapeutics, Inc.: Targets and Partners
- Acorda Therapeutics, Inc.: Top Deals 2011 - 2015YTD*
- Acorda Therapeutics, Inc.: Advisors
- Acorda Therapeutics, Inc.: Top Legal Advisors
- Acorda Therapeutics, Inc.: Top Financial Advisors
- Acorda Therapeutics, Inc.: Mergers and Acquisitions
- Acorda Therapeutics, Inc.: Partnership
- Acorda Therapeutics, Inc.: Recent Developments
- Acorda Therapeutics, Inc.: News and Events Summary
- Acorda Therapeutics, Inc.: Contracts
- Acorda Therapeutics, Inc.: Corporate Governance
- Acorda Therapeutics, Inc.: Financial Performance
- Acorda Therapeutics, Inc.: Grants
- Acorda Therapeutics, Inc.: Research & Development
- Appendix
- Contact Us
- Methodology
- Definitions
- About Market Line
- List of Tables
- Table 1: Acorda Therapeutics, Inc.: Key Facts
- Table 2: Acorda Therapeutics, Inc.: Key Employees
- Table 3: Acorda Therapeutics, Inc.: Key Competitors
- Table 4: Acorda Therapeutics, Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
- Table 5: Acorda Therapeutics, Inc.: M&A Average Deal Size - Value (US$m)
- Table 6: Acorda Therapeutics, Inc.: Targets and Partners
- Table 7: Acorda Therapeutics, Inc.: Top Deals 2011 - 2015YTD*
- Table 8: Acorda Therapeutics, Inc.: Legal Advisor Ranking by Value (US$m)
- Table 9: Acorda Therapeutics, Inc.: Financial Advisor Ranking by Value (US$m)
- Table 10: Acorda Therapeutics, Inc.: M&A Volume and Value Trend (2011 - YTD*2015)
- Table 11: Acorda Therapeutics, Inc.: M&A Activity by Geography (2011 - YTD*2015)
- Table 12: Acorda Therapeutics, Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
- Table 13: Acorda Therapeutics, Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)
- Table 14: Acorda Therapeutics, Inc.: News and Events Summary
- Table 15: Acorda Therapeutics, Inc.: Contracts
- Table 16: Acorda Therapeutics, Inc.: Corporate Governance
- Table 17: Acorda Therapeutics, Inc.: Financial Performance
- Table 18: Acorda Therapeutics, Inc.: Grants
- Table 19: Acorda Therapeutics, Inc.: Research & Development
- List of Figures
- Figure 1: Acorda Therapeutics, Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
- Figure 2: Acorda Therapeutics, Inc.: M&A Average Deal Size - Value (US$m)
- Figure 3: Acorda Therapeutics, Inc.: M&A Volume and Value Trend (2011 - YTD*2015)
- Figure 4: Acorda Therapeutics, Inc.: M&A Activity by Geography (2011 - YTD*2015)
- Figure 5: Acorda Therapeutics, Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
- Figure 6: Acorda Therapeutics, Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)